PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
04-Oct-2023 Cancer Nanomedicine Market Size Expected to Reach USD 445.67 Billion with Growing CAGR of 12% by 2030 The Wire Times
04-Oct-2023 Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference Businesswire
04-Oct-2023 PharmaVoice Recognizes Healthtech CEO Peter Kirk as One of 100 Most Inspiring Leaders in the Life Sciences Industry Businesswire
04-Oct-2023 New Videojet 1880 Series Continuous Inkjet Printers Deliver High-Speed, Micro-codes with Advanced Digital Connectivity Businesswire
04-Oct-2023 Aventa Genomics Announces Launch of Aventa FusionPlus, the First 3D Genomics Clinical Test for Patients with Solid Cancers Businesswire
04-Oct-2023 Commure Combines with Athelas to Create a Pioneering Platform Dedicated to Transforming Health Systems Businesswire
04-Oct-2023 3 Day Online Course: Pharmacovigilance for Drug Safety, Regulatory Affairs and PV Auditors - Broadening your Knowledge Training Course (January 31, 2024 February 2, 2024) - ResearchAndMarkets.com Businesswire
04-Oct-2023 Axine Water Technologies Expands Leadership Team to Support Its Growth in Industrial Wastewater Treatment of PFAS and Other Contaminants Businesswire
04-Oct-2023 Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded Additional Financial Grants from Japanese Government Businesswire
04-Oct-2023 Erdheim Chester Disease Market is Likely to Upsurge at USD 7.96 Billion Globally by 2029 The Wire Times
04-Oct-2023 NEW DEVELOPMENT IN THE TREATMENT OF ALZHEIMER’S DISEASE Luye Pharma Ltd
04-Oct-2023 Ankyra Therapeutics Announces Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate ANK-101 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors Businesswire
04-Oct-2023 IMIDomics Announces Strategic Agreement with WuXi Biologics to Advance IMB1001 Antibody Development for Immune-Mediated Inflammatory Diseases Businesswire
04-Oct-2023 ATUM Partners with Anagram Therapeutics to Extend Collaboration to Develop Orally Delivered Enzyme Therapies for Malabsorption and Nutrient Metabolism Disorders Businesswire
04-Oct-2023  Bolt Threads to Become a Public Company, Growing its Pioneering Biomaterials Platform Through Business Combination With Golden Arrow Merger Corp. Businesswire
04-Oct-2023 AI Proteins Announces the Appointment of Dr. Robert Stein to its Scientific Advisory Board Businesswire
04-Oct-2023 Odyssey Therapeutics Appoints Jeremy Sokolove, MD as Chief Medical Officer Businesswire
04-Oct-2023 Autobahn Therapeutics to Present at Upcoming Investor Conferences Businesswire
04-Oct-2023 Starton Therapeutics Doses First Patient in Landmark STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma Businesswire
04-Oct-2023 Aerium Therapeutics Advances Next Generation Antibodies to Protect Immunocompromised Persons Against COVID-19 Businesswire